Research Article

The Effect of Ivabradine on the Human Atrial Myocardial Contractility in an In Vitro Study

Table 1

Summary of the medical profiles and medications of the patients.

Donor Nr.GroupAge (years)GenderBMI (kg/m2)DiseasesCardiac functionSurgeryMedications

D 001Control63m23CAD, AHT, DMNormalIsolated CABGASA, bisoprolol, amlodipine

D 002Control66f26CAD, AHT, ND, goutNormalIsolated CABGASA, bisoprolol, furosemide, amlodipine, vitamin D

D 004Control64f39CAD, AHTNormalIsolated CABGASA, clopidogrel, bisoprolol, simvastatin, furosemide, amlodipine

D 005Control59f24CAD, AHT, NDNormalIsolated CABGASA, ramipril

D 006Control49m31CAD, AHT, ND, psoriasisNormalIsolated CABGASA, bisoprolol, simvastatin, amlodipine

D 0082 μMol71m29CAD, IBSNormalIsolated CABGASA, clopidogrel, simvastatin

D 0092 μMol60f22CAD, AVS, PADModerately reducedCABG + AVRASA, clopidogrel, furosemide, amlodipine, ramipril

D 0102 μMol75m33CAD, DM, NDNormalIsolated CABGASA, simvastatin, furosemide, metformin

D 0112 μMol69f28CAD, AHTNormalIsolated CABGASA, clopidogrel, bisoprolol, simvastatin

D 0122 μMol74f36CAD, DMNormalIsolated CABGASA, bisoprolol, metformin, amlodipine

D 013200 nMol67m31CAD, AHT, DM, NDNormalIsolated CABGclopidogrel, bisoprolol, furosemide, metformin, amlodipine, lorazepam

D 015200 nMol62f43CAD, AHT, NDNormalIsolated CABGASA

D 021200 nMol69m26CAD, AHT, ND, PADNormalIsolated CABGASA, clopidogrel, simvastatin

D 022200 nMol55m34CAD, AVS, MVI, AHTNormalCABG + AVR + MVRASA, bisoprolol, furosemide, vitamin d

D 023200 nMol27m24AVS, NDNormalIsolated AVRASA

D 02760 nMol77m25CAD, AHT, DM, dNNormalIsolated CABGASA

D 02860 nMol77m30CAD, AHT, DM, ND, dNNormalIsolated CABGASA, metoprolol, ramipril

D 02960 nMol59f38CAD, AHT, DMNormalIsolated CABGASA, bisoprolol, simvastatin, amlodipine

D 03060 nMol71m27CAD, AVS, AHT, PADNormalIsolated AVRASA, bisoprolol, amlodipine, phenprocoumon

D 03160 nMol65f34CAD, MVI, AHTNormalIsolated CABGASA, bisoprolol, amlodipine

CAD: coronary artery disease, AHT: arterial hypertension, DM: diabetes mellitus, ND: nicotine dependency, IBS: irritable bowel syndrome, AVS: aortic valve stenosis, PAD: peripheral artery disease, MVI: mitral valve insufficiency, dN: diabetic nephropathy, ASA: acetylsalicylic acid. Ivabradine has affected the force of contraction significantly in vitro (). However, force of contraction decreased in both the control group (93.5 ± 4.7%) and the second group (94.1 ± 4.5%, ), force of contraction remained unchanged in the third group (101.0 ± 4.1%, ), and force of contraction increased significantly in the fourth group (108.9 ± 11.6%, ).